THE ROLE We are seeking a Scientist, Molecular Cloning to join our cloning team. In this role, you will apply a range of assembly and host strategies to viral vector plasmids with challenging sequence features, diagnose and resolve failed builds, and confirm each construct meets quality standards. Working in a service-center model alongside the RNA production, NGS, and automation teams, you will help create and implement scalable, reproducible methods that support project teams across the company. You will build your expertise in difficult-construct cloning while keeping rigorous records and contributing to shared protocols and best practices.
KEY RESPONSIBILITIES - Design and execute cloning strategies for difficult viral constructs, including repeat-rich and GC-rich sequences, and toxic or recombination-prone inserts.
- Select and compare approaches for each build: assembly method (Gibson, Golden Gate, restriction/ligation, in vitro or in vivo recombination), recombination-deficient and stability-optimized hosts, low-copy backbones, and growth conditions.
- Troubleshoot failed or unstable clones by diagnosing deletions, rearrangements, and toxicity, then document root cause and the fix that worked.
- Verify constructs with orthogonal methods: restriction mapping, Sanger, long-read sequencing (nanopore or PacBio), and short-read NGS, with a clear pass/fail standard for each build.
- Partner with the RNA production, NGS, and automation teams to move proven workflows into scalable, reproducible protocols.
- Support project teams as a service-center scientist: scope requests, give realistic turnaround estimates, and communicate progress and risks.
- Maintain complete records in Benchling and contribute to SOPs, build-strategy playbooks, and a library of lessons learned on difficult sequences.
- Mentor and train cloning staff on difficult-construct methods.
PROFESSIONAL EXPERIENCE & QUALIFICATIONS - PhD in molecular biology, virology, biochemistry, genetics, or a related field with 0-2 years of postdoctoral or industry experience, or an MS with 8+ years of directly relevant industry experience.
- Demonstrated hands-on success cloning sequences, such as repeat-rich, structured, GC-rich, or toxic inserts with the ability to describe specific cases and what solved them.
- Working knowledge of viral vector genome architecture and why it complicates cloning in bacteria.
- Strong command of modern assembly methods and recombination-aware host and plasmid selection.
- Experience verifying large or repetitive constructs with long-read and next-generation sequencing, and interpreting the data.
- Rigorous documentation habits and experience with an ELN or LIMS; Benchling preferred.
- Clear communicator who can work with internal customers on scope, timelines, and trade-offs.
Preferred Qualifications
- Direct experience building AAV, lentiviral, or other viral vector plasmids, including vector genome and packaging/helper constructs.
- Familiarity with synthetic DNA vendors' limits on difficult sequences and with strategies for sub-assembly, codon or sequence refactoring, and intron or spacer insertion to improve stability.
- Experience with liquid-handling automation and designing cloning workflows for higher throughput.
- Experience working in a service-center or core-facility setting with multiple stakeholders and competing priorities.
- Experience developing SOPs and QC specifications, and training others on them.
- Familiarity with working under biosafety requirements for viral vector work (BSL-1/BSL-2) and institutional biosafety committee processes.
Location: Cambridge, MA
The salary range for this role is $100,000 - $126,500. Compensation for the role will depend on a number of factors, including a candidate's qualifications, skills, competencies, and experience. Terrana Biosciences, Inc. currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on Terrana Biosciences, Inc.'s good faith estimate as of the date of publication and may be modified in the future.